Browsing by Subject "calcific aortic valve disease"

Now showing items 1-1 of 1

    • A Novel Role for Sclerostin in Aortic Valve Stenosis 
      Joll II, Jeffery Ethan; 0000-0001-7941-6380 (2022-03-15)
      Department: Biomedical Engineering
      In 2017 the sclerostin targeting monoclonal antibody Romosozumab was approved as a treatment for post-menopausal osteoporosis (PMO) despite cardiovascular side effects discovered in clinical trials. Previous studies indicated ...